Effect of estradiol on neuronal Swedish-mutated beta-amyloid precursor protein metabolism: reversal by astrocytic cells.

No abstract is available for this paper.

• Publication year

  2000

• Venue

  Biochemical and Biophysical Research Communications - BBRC

• Publication date

  2000-04-29

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1006/BBRC.2000.2581PMID 10777685
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• A special type of senile plaque, possibly an initial stage

  2004cited by this paper
• Estrogen modulates neuronal Bcl-xL expression and beta-amyloid-induced apoptosis: relevance to Alzheimer's disease.

  2001cited by this paper
• Regulation of Amyloid Precursor Protein Cleavage

  1999cited by this paper
• Estrogen reduces neuronal generation of Alzheimer beta-amyloid peptides.

  1998cited by this paper
• Human apolipoprotein E allele-specific brain expressing transgenic mice.

  1998cited by this paper
• Estrogen reduces neuronal generation of Alzheimer β-amyloid peptides

  1998cited by this paper
• The epidemiology of estrogen replacement therapy and Alzheimer's disease

  1997cited by this paper
• Familial Alzheimer's Disease–Linked Presenilin 1 Variants Elevate Aβ1–42/1–40 Ratio In Vitro and In Vivo

  1996cited by this paper
• Distinct Properties of Neuronal and Astrocytic Endopeptidase 3.4.24.16: A Study on Differentiation, Subcellular Distribution, and Secretion Processes

  1996cited by this paper
• Effect of oestrogen during menopause on risk and age at onset of Alzheimer's disease.

  1996cited by this paper
• Familial Alzheimer's disease-linked presenilin 1 variants elevate Abeta1-42/1-40 ratio in vitro and in vivo.

  1996cited by this paper
• Processing of the β‐Amyloid Precursor Protein and Its Regulation in Alzheimer's Disease

  1995cited by this paper
• LDL receptor-related protein, a multifunctional ApoE receptor, binds secreted beta-amyloid precursor protein and mediates its degradation.

  1995cited by this paper
• Processing of the beta-amyloid precursor protein and its regulation in Alzheimer's disease.

  1995cited by this paper
• The Swedish mutation causes early-onset Alzheimer's disease by β-secretase cleavage within the secretory pathway

  1995cited by this paper
• Estrogen regulates metabolism of Alzheimer amyloid beta precursor protein.

  1994cited by this paper
• Apolipoprotein E4 allele in a population–based study of early–onset Alzheimer's disease

  1994cited by this paper
• Evidence for excitoprotective and intraneuronal calcium-regulating roles for secreted forms of the beta-amyloid precursor protein.

  1993cited by this paper
• Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families.

  1993cited by this paper
• Evidence for excitoprotective and intraneuronal calcium-regulating roles for secreted forms of the β-amyloid precursor protein

  1993cited by this paper
• Apolipoprotein E in sporadic Alzheimer's disease: allelic variation and receptor interactions.

  1993cited by this paper
• Differential APP gene expression in rat cerebral cortex, meninges, and primary astroglial, microglial and neuronal cultures

  1991cited by this paper
• Reactive astrocytes--a review.

  1990cited by this paper
• Estrogen treatment enhances survival of cultured fetal rat amygdala neurons in a defined medium.

  1986cited by this paper
• Amyloid plaque core protein in Alzheimer disease and Down syndrome.

  1985cited by this paper
• Fibrous Astrocytes in Senile Dementia of the Alzheimer Type

  1981cited by this paper

• The Interaction Between NF-κB and Estrogen in Alzheimer’s Disease

  2022cites this paper
• Estrogen Signaling Based Current and Potential Therapies Against Obesity and Related Diseases

  2021cites this paper
• Estrogen Signaling in Alzheimer’s Disease: Molecular Insights and Therapeutic Targets for Alzheimer’s Dementia

  2020cites this paper
• Gender differences in the relationships among neurosteroid serum levels, cognitive function, and quality of life

  2018cites this paper
• gender differences in the relationships among neurosteroid serum levels, cognitive function, and quality of life

  2018cites this paper
• Higher level of circulating estradiol is associated with lower frequency of cognitive impairment in Southeast China

  2017cites this paper
• Sex Hormone Decline and Amyloid β Synthesis, Transport and Clearance in the Brain

  2016cites this paper
• Effects of sex steroid hormones on the neurovascular unit in the mouse hypothalamus

  2016cites this paper
• ALZHEIMER’S DISEASE CAUSES AND MANGEMNT

  2014cites this paper
• Sex hormones, aging, and Alzheimer's disease.

  2012influential citation
• Protective actions of sex steroid hormones in Alzheimer's disease.

  2009influential citation
• Impact of sex steroids on neuroinflammatory processes and experimental multiple sclerosis.

  2009cites this paper
• Androgen regulation of β-amyloid protein and the risk of Alzheimer’s disease

  2008cites this paper
• Androgen regulation of beta-amyloid protein and the risk of Alzheimer's disease.

  2008cites this paper
• Cortical Cholinergic Lesion Causes Aβ Deposition: Cholinergic-Amyloid Fusion Hypothesis

  2008cites this paper
• Progesterone receptors: form and function in brain.

  2008cites this paper
• Effects of β-amyloid peptide and estrogen on platelet mitochondrial function of Sprague-Dawley rats

  2007cites this paper
• Agonist Activity of the 3‐Hydroxy Metabolites of Tibolone Through the Oestrogen Receptor in the Mouse N20.1 Oligodendrocyte Cell Line and Normal Human Astrocytes

  2007cites this paper
• Drug discovery

  2007cites this paper
• Androgens, aging, and Alzheimer's disease

  2006cites this paper
• Cortical Cholinergic Deafferentation Induces Aβ Deposition

  2005cites this paper
• Glycogen synthase kinase 3beta links neuroprotection by 17beta-estradiol to key Alzheimer processes.

  2005cites this paper
• Molecular endocrinology and physiology of the aging central nervous system.

  2005cites this paper
• Glycogen synthase kinase 3β links neuroprotection by 17β-estradiol to key Alzheimer processes

  2005cites this paper
• Lack of protective effect of estrogens on cerebral Aβ levels in intact female and male APP transgenic mice

  2005cites this paper
• Hormonal and non-hormonal factors associated with cognition in post-menopausal women

  2004cites this paper
• Neuroendocrinology of Neurodegenerative Diseases

  2003cites this paper
• Insights from Transgenic Mouse Models

  2003cites this paper
• ReviewGenetics, lifestyle and the roles of amyloid β and oxidative stress in Alzheimer’s disease

  2003cites this paper
• The role of hormone replacement therapy in the prevention of Alzheimer disease.

  2002cites this paper
• Chronic gliosis triggers Alzheimer's disease-like processing of amyloid precursor protein.

  2002cites this paper
• 17α-estradiol and 17β-estradiol treatments are effective in lowering cerebral amyloid-β levels in AβPPSWE transgenic mice

  2002cites this paper
• 17Alpha-estradiol and 17beta-estradiol treatments are effective in lowering cerebral amyloid-beta levels in AbetaPPSWE transgenic mice.

  2002cites this paper
• Estrogen and Alzheimer’s Disease

  2002cites this paper
• Estrogen induces a rapid secretion of amyloid beta precursor protein via the mitogen-activated protein kinase pathway.

  2001cites this paper
• Alzheimer's disease: its diagnosis and pathogenesis.

  2001cites this paper
• Altered expression of apolipoprotein E, amyloid precursor protein and presenilin-1 is associated with chronic reactive gliosis in rat cortical tissue.

  2001cites this paper